Advertisement
Advertisement
ANGO
AngioDynamics, Inc.
9.73
USDSponsored
-0.36
-3.58%
Apr 10, 13:06 UTC -4
Open
ANGO Earnings Reports
Positive Surprise Ratio
ANGO beat 29 of 41 last estimates.
71%
Next Report
Date of Next Report
Jul 13, 2026
Estimate for Q4 26 (Revenue/ EPS)
$82.01M
/-$0.09
Implied change from Q3 26 (Revenue/ EPS)
+4.57%
/-550.00%
Implied change from Q4 25 (Revenue/ EPS)
+2.31%
/+200.00%
AngioDynamics, Inc. earnings per share and revenue
On Apr 02, 2026, ANGO reported earnings of 0.02 USD per share (EPS) for Q3 26, beating the estimate of -0.11 USD, resulting in a 117.83% surprise. Revenue reached 78.42 million, compared to an expected 78.30 million, with a 0.15% difference. The market reacted with a -13.65% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 6 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 82.01 million USD, implying an decrease of -550.00% EPS, and increase of 4.57% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were AngioDynamics, Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, AngioDynamics, Inc. reported EPS of $0.02, beating estimates by 117.83%, and revenue of $78.42M, 0.15% above expectations.
How did the market react to AngioDynamics, Inc.'s Q3 2026 earnings?
The stock price moved down -13.65%, changed from $11.94 before the earnings release to $10.31 the day after.
When is AngioDynamics, Inc. expected to report next?
The next earning report is scheduled for Jul 13, 2026.
What are the forecasts for AngioDynamics, Inc.'s next earnings report?
Based on 6
analysts, AngioDynamics, Inc. is expected to report EPS of -$0.09 and revenue of $82.01M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement